BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38144556)

  • 21. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
    Jiang X; Eales JM; Scannali D; Nazgiewicz A; Prestes P; Maier M; Denniff M; Xu X; Saluja S; Cano-Gamez E; Wystrychowski W; Szulinska M; Antczak A; Byars S; Skrypnik D; Glyda M; Król R; Zywiec J; Zukowska-Szczechowska E; Burrell LM; Woolf AS; Greenstein A; Bogdanski P; Keavney B; Morris AP; Heagerty A; Williams B; Harrap SB; Trynka G; Samani NJ; Guzik TJ; Charchar FJ; Tomaszewski M
    Eur Heart J; 2020 Dec; 41(48):4580-4588. PubMed ID: 33206176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France.
    Hoang VT; Colson P; Levasseur A; Delerce J; Lagier JC; Parola P; Million M; Fournier PE; Raoult D; Gautret P
    Infect Genet Evol; 2021 Nov; 95():105092. PubMed ID: 34571275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes.
    Qadir MMF; Bhondeley M; Beatty W; Gaupp DD; Doyle-Meyers LA; Fischer T; Bandyopadhyay I; Blair RV; Bohm R; Rappaport J; Lazartigues E; Heide RSV; Kolls JK; Qin X; Mauvais-Jarvis F
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34241597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
    Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
    Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Hu S; Hu Z; Qin J; Lin C; Jiang X
    Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
    Sartore G; Ragazzi E; Faccin L; Lapolla A
    Med Hypotheses; 2020 Nov; 144():110247. PubMed ID: 33254553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.
    Jayaswal SK; Singh S; Malik PS; Venigalla SK; Gupta P; Samaga SN; Hota RN; Bhatia SS; Gupta I
    Diabetes Metab Syndr; 2021; 15(5):102248. PubMed ID: 34412000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological post-mortem findings in lungs infected with SARS-CoV-2.
    Damiani S; Fiorentino M; De Palma A; Foschini MP; Lazzarotto T; Gabrielli L; Viale PL; Attard L; Riefolo M; D'Errico A
    J Pathol; 2021 Jan; 253(1):31-40. PubMed ID: 32930394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung.
    Miura Y; Ohkubo H; Nakano A; Bourke JE; Kanazawa S
    Front Immunol; 2022; 13():1028613. PubMed ID: 36405683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and COVID-19; A Bidirectional Interplay.
    Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
    Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed Analyses of the Expression Patterns of Potential Severe Acute Respiratory Syndrome Coronavirus 2 Receptors in the Human Heart Using Single-Nucleus RNA Sequencing.
    Ren J; Zhang Y; Liu S; Li X; Sun X
    Front Cardiovasc Med; 2021; 8():757362. PubMed ID: 34917662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage.
    Bass A; Liu Y; Dakshanamurthy S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular metabolic basis of altered immunity in the lungs of patients with COVID-19.
    Li S; Zhao F; Ye J; Li K; Wang Q; Du Z; Yue Q; Wang S; Wu Q; Chen H
    Med Microbiol Immunol; 2022 Feb; 211(1):49-69. PubMed ID: 35022857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.
    Edler C; Schröder AS; Aepfelbacher M; Fitzek A; Heinemann A; Heinrich F; Klein A; Langenwalder F; Lütgehetmann M; Meißner K; Püschel K; Schädler J; Steurer S; Mushumba H; Sperhake JP
    Int J Legal Med; 2020 Jul; 134(4):1275-1284. PubMed ID: 32500199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.